Apyx Medical Corp. (APYX) Tops Q3 EPS by 5c ; Offers Guidance

Apyx Medical Corp. (NASDAQ: APYX) reported Q3 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $12 million.

GUIDANCE:

Apyx Medical Corp. sees FY2025 revenue of $50.5-52.5 million, versus the consensus of $49.99 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Fiserv tender offer draws $1.33B in notes by expiration